North America Neuromodulation Devices Market Outlook to 2025

GlobalData
146 Pages - GLDATA65691
$5,995.00

Summary

GlobalData’s new report, North America Neuromodulation Devices Market Outlook to 2025, provides key market data on the North America Neuromodulation Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Leads, Peripheral Nerve Stimulators (PNS), Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS) and Vagus Nerve Stimulators (VNS).

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Neuromodulation Devices market segments - Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Leads, Peripheral Nerve Stimulators (PNS), Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS) and Vagus Nerve Stimulators (VNS)..
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
- 2017 company share and distribution share data for Neuromodulation Devices market.
- Global corporate-level profiles of key companies operating within the North America Neuromodulation Devices market.
- Key players covered include Abbott Healthcare Pvt Ltd, Boston Scientific Corp, Medtronic plc and others.

Reasons to buy

- Develop business strategies by identifying the key market categories poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.



Companies Mentioned
Medtronic Plc
Abbott Laboratories
Boston Scientific Corp
Nevro Corp
LivaNova PLC

'

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Neuromodulation Devices Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Neuromodulation Devices Market, North America 7
3.1 Neuromodulation Devices Market, North America, Revenue ($m), 2015-2025 7
3.2 Neuromodulation Devices Market, North America, Revenue ($m), 2015-2025 9
3.3 Neuromodulation Devices Market, North America, Volume (Units), 2015-2025 12
3.4 Neuromodulation Devices Market, North America, Volume (Units), 2015-2025 14
3.5 Neuromodulation Devices Market, North America, Company Share by Revenue ($m), 2017 17
4 Neuromodulation Devices Market, Canada 19
4.1 Neuromodulation Devices Market, Canada, Revenue ($m), 2015-2025 19
4.2 Neuromodulation Devices Market, Canada, Volume (Units), 2015-2025 22
4.3 Neuromodulation Devices Market, Canada, Average Price ($), 2015-2025 25
4.4 Neuromodulation Devices Market, Canada, Distribution Share by Revenue ($m), 2017 27
4.5 Neuromodulation Devices Market, Canada, Company Share by Revenue ($m), 2017 28
5 Neuromodulation Devices Market, Mexico 30
5.1 Neuromodulation Devices Market, Mexico, Revenue ($m), 2015-2025 30
5.2 Neuromodulation Devices Market, Mexico, Volume (Units), 2015-2025 33
5.3 Neuromodulation Devices Market, Mexico, Average Price ($), 2015-2025 36
5.4 Neuromodulation Devices Market, Mexico, Distribution Share by Revenue ($m), 2017 38
5.5 Neuromodulation Devices Market, Mexico, Company Share by Revenue ($m), 2017 39
6 Neuromodulation Devices Market, United States 41
6.1 Neuromodulation Devices Market, United States, Revenue ($m), 2015-2025 41
6.2 Neuromodulation Devices Market, United States, Volume (Units), 2015-2025 44
6.3 Neuromodulation Devices Market, United States, Average Price ($ , 2015-2025 47
6.4 Neuromodulation Devices Market, United States, Distribution Share by Revenue ($m), 2017 49
6.5 Neuromodulation Devices Market, United States, Company Share by Revenue ($m), 2017 50
7 Overview of Key Companies in North America Neuromodulation Devices Market 52
7.1 Medtronic Plc 52
7.2 Abbott Laboratories 52
7.3 Boston Scientific Corp 52
7.4 Nevro Corp 52
7.5 LivaNova PLC 53
8 Neuromodulation Devices Market Pipeline Products 54
9 Recent Developments 66
9.1 Corporate Communications 66
9.2 Financial Announcements 80
9.3 Government and Public Interest 128
9.4 Legal And Regulatory 128
9.5 Other Significant Developments 129
9.6 Product News 131
9.7 Strategy And Business Planning 135
10 Appendix 137
10.1 Research Methodology 138
10.2 GlobalData Consulting 142
10.3 Contact Us 143
10.4 Disclaimer 143

1.1 List of Tables
Table 1: Neuromodulation Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2015-2025 10
Table 2: Neuromodulation Devices Market, North America, Revenue ($m), Historic, USD Constant, 2015-2020 12
Table 3: Neuromodulation Devices Market, North America, Revenue ($m), Forecast, USD Constant, 2021-2025 13
Table 4: Neuromodulation Devices Market, North America, Volume (Units), 2015-2025 15
Table 5: Neuromodulation Devices Market, North America, Volume (Units), 2015-2020 17
Table 6: Neuromodulation Devices Market, North America, Volume (Units), 2021-2025 18
Table 7: Neuromodulation Devices Market, North America, Company Share by Revenue ($m), USD Constant, 2017 20
Table 8: Neuromodulation Devices Market, Canada, Revenue ($m), USD Constant, 2015-2020 22
Table 9: Neuromodulation Devices Market, Canada, Revenue ($m), USD Constant, 2021-2025 23
Table 10: Neuromodulation Devices Market, Canada, Volume (Units), 2015-2020 25
Table 11: Neuromodulation Devices Market, Canada, Volume (Units), 2021-2025 26
Table 12: Neuromodulation Devices Market, Canada, Average Price ($), 2015-2020 27
Table 13: Neuromodulation Devices Market, Canada, Average Price ($), 2021-2025 28
Table 14: Neuromodulation Devices Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2017 29
Table 15: Neuromodulation Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2017 31
Table 16: Neuromodulation Devices Market, Mexico, Revenue ($m), USD Constant, 2015-2020 33
Table 17: Neuromodulation Devices Market, Mexico, Revenue ($m), USD Constant, 2021-2025 34
Table 18: Neuromodulation Devices Market, Mexico, Volume (Units), 2015-2020 36
Table 19: Neuromodulation Devices Market, Mexico, Volume (Units), 2021-2025 37
Table 20: Neuromodulation Devices Market, Mexico, Average Price ($), 2015-2020 38
Table 21: Neuromodulation Devices Market, Mexico, Average Price ($), 2021-2025 39
Table 22: Neuromodulation Devices Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2017 40
Table 23: Neuromodulation Devices Market, Mexico, Company Share by Revenue ($m), USD Constant, 2017 42
Table 24: Neuromodulation Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 44
Table 25: Neuromodulation Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 45
Table 26: Neuromodulation Devices Market, United States, Volume (Units), 2015-2020 47
Table 27: Neuromodulation Devices Market, United States, Volume (Units), 2021-2025 48
Table 28: Neuromodulation Devices Market, United States, Average Price ($), 2015-2020 49
Table 29: Neuromodulation Devices Market, United States, Average Price ($), 2021-2025 50
Table 30: Neuromodulation Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 51
Table 31: Neuromodulation Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2017 53
Table 32: Neuromodulation Devices Market Pipeline Products 56
Table 33: Total Number of Primary Research Participants, Neurology Devices Market, by Country 142

1.2 List of Figures
Figure 1: Neuromodulation Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2015-2025 10
Figure 2: Neuromodulation Devices Market, North America, Revenue ($m), Historic, USD Constant, 2015-2025 12
Figure 3: Neuromodulation Devices Market, North America, Volume (Units), 2015-2025 15
Figure 4: Neuromodulation Devices Market, North America, Volume (Units), 2015-2025 17
Figure 5: Neuromodulation Devices Market, North America, Company Share (%) 2017 20
Figure 6: Neuromodulation Devices Market, Canada, Revenue ($m), USD Constant, 2015-2025 22
Figure 7: Neuromodulation Devices Market, Canada, Volume (Units), 2015-2025 25
Figure 8: Neuromodulation Devices Market, Canada, Company Share (%) 2017 31
Figure 9: Neuromodulation Devices Market, Mexico, Revenue ($m), USD Constant, 2015-2025 33
Figure 10: Neuromodulation Devices Market, Mexico, Volume (Units), 2015-2025 36
Figure 11: Neuromodulation Devices Market, Mexico, Company Share (%) 2017 42
Figure 12: Neuromodulation Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 44
Figure 13: Neuromodulation Devices Market, United States, Volume (Units), 2015-2025 47
Figure 14: Neuromodulation Devices Market, United States, Company Share (%) 2017 53

$5,995.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports